IRIS Accounts Production v24.1.0.578 12333346 director 1.1.23 31.12.23 31.12.23 10.5.24 0 0 false true true false false true false Auditors Opinion Fair value model iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh123333462022-12-31123333462023-12-31123333462023-01-012023-12-31123333462021-12-31123333462022-01-012022-12-31123333462022-12-3112333346ns15:EnglandWales2023-01-012023-12-3112333346ns14:PoundSterling2023-01-012023-12-3112333346ns10:Director12023-01-012023-12-3112333346ns10:PrivateLimitedCompanyLtd2023-01-012023-12-3112333346ns10:SmallEntities2023-01-012023-12-3112333346ns10:Audited2023-01-012023-12-3112333346ns10:SmallCompaniesRegimeForDirectorsReport2023-01-012023-12-3112333346ns10:SmallCompaniesRegimeForAccounts2023-01-012023-12-3112333346ns10:FullAccounts2023-01-012023-12-3112333346ns10:Director22023-01-012023-12-3112333346ns10:RegisteredOffice2023-01-012023-12-3112333346ns5:CurrentFinancialInstruments2023-12-3112333346ns5:CurrentFinancialInstruments2022-12-3112333346ns5:ShareCapital2023-12-3112333346ns5:ShareCapital2022-12-3112333346ns5:RetainedEarningsAccumulatedLosses2023-12-3112333346ns5:RetainedEarningsAccumulatedLosses2022-12-3112333346ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-12-3112333346ns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-12-31
REGISTERED NUMBER: 12333346 (England and Wales)








REPORT OF THE DIRECTOR AND

FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2023

FOR

KDL MEDICAL LIMITED

KDL MEDICAL LIMITED (REGISTERED NUMBER: 12333346)






CONTENTS OF THE FINANCIAL STATEMENTS
for the Year Ended 31 December 2023




Page

Company Information 1

Report of the Director 2

Balance Sheet 3

Notes to the Financial Statements 4 to 5


KDL MEDICAL LIMITED

COMPANY INFORMATION
for the Year Ended 31 December 2023







DIRECTOR: Mr D Zhou





REGISTERED OFFICE: Unit 14
Cowley Mill Road
Uxbridge
Greater London
UB8 2DB





REGISTERED NUMBER: 12333346 (England and Wales)





AUDITORS: C. Wilkinson & Co.
Chartered Accountants and Statutory Auditors
Britannic House
657 Liverpool Road
Irlam
Manchester
Greater Manchester
M44 5XD

KDL MEDICAL LIMITED (REGISTERED NUMBER: 12333346)

REPORT OF THE DIRECTOR
for the Year Ended 31 December 2023

The director presents his report with the financial statements of the company for the year ended 31 December 2023.

DIRECTOR
Mr D Zhou held office during the whole of the period from 1 January 2023 to the date of this report.

The director shown below was in office at 31 December 2023 but did not hold any interest in the Ordinary shares of £1 each at 1 January 2023 or 31 December 2023.

Mr D Zhou

STATEMENT OF DIRECTOR'S RESPONSIBILITIES
The director is responsible for preparing the Report of the Director and the financial statements in accordance with applicable law and regulations.

Company law requires the director to prepare financial statements for each financial year. Under that law the director has elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the director must not approve the financial statements unless he is satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the director is required to:

-select suitable accounting policies and then apply them consistently;
-make judgements and accounting estimates that are reasonable and prudent;
-prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The director is responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable him to ensure that the financial statements comply with the Companies Act 2006. He is also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

STATEMENT AS TO DISCLOSURE OF INFORMATION TO AUDITORS
So far as the director is aware, there is no relevant audit information (as defined by Section 418 of the Companies Act 2006) of which the company's auditors are unaware, and he has taken all the steps that he ought to have taken as a director in order to make himself aware of any relevant audit information and to establish that the company's auditors are aware of that information.

AUDITORS
The auditors, C. Wilkinson & Co., will be proposed for re-appointment at the forthcoming Annual General Meeting.

This report has been prepared in accordance with the provisions of Part 15 of the Companies Act 2006 relating to small companies.

ON BEHALF OF THE BOARD:





Mr H Zhang - Director


10 May 2024

KDL MEDICAL LIMITED (REGISTERED NUMBER: 12333346)

BALANCE SHEET
31 December 2023

31.12.23 31.12.22
Notes £    £   
FIXED ASSETS
Investment property 4 1,261,280 1,261,280

CURRENT ASSETS
Debtors 5 6,735 5,583
Cash at bank 615,846 631,378
622,581 636,961
CREDITORS
Amounts falling due within one year 6 (2,010,785 ) (2,002,925 )
NET CURRENT LIABILITIES (1,388,204 ) (1,365,964 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

(126,924

)

(104,684

)

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings (127,024 ) (104,784 )
SHAREHOLDERS' FUNDS (126,924 ) (104,684 )

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the director and authorised for issue on 10 May 2024 and were signed by:





Mr H Zhang - Director


KDL MEDICAL LIMITED (REGISTERED NUMBER: 12333346)

NOTES TO THE FINANCIAL STATEMENTS
for the Year Ended 31 December 2023

1. STATUTORY INFORMATION

KDL Medical Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Investment property
Investment property is shown at most recent valuation. Any aggregate surplus or deficit arising from changes in fair value is recognised in profit or loss.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Foreign currencies
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2022 - NIL).

KDL MEDICAL LIMITED (REGISTERED NUMBER: 12333346)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the Year Ended 31 December 2023

4. INVESTMENT PROPERTY
Total
£   
FAIR VALUE
At 1 January 2023
and 31 December 2023 1,261,280
NET BOOK VALUE
At 31 December 2023 1,261,280
At 31 December 2022 1,261,280

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.23 31.12.22
£    £   
Other debtors 6,735 5,583

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.23 31.12.22
£    £   
Amounts owed to group undertakings 1,999,900 1,999,900
Taxation and social security 7,859 -
Other creditors 3,026 3,025
2,010,785 2,002,925

7. DISCLOSURE UNDER SECTION 444(5B) OF THE COMPANIES ACT 2006

The Report of the Auditors was unqualified.

Colin Wilkinson (Senior Statutory Auditor)
for and on behalf of C. Wilkinson & Co.

8. RELATED PARTY DISCLOSURES

Creditors amount in the account includes £1,999,900 (2022 - £1,999,900) loan owed to Shanghai Kindly Enterprises Development Group Co. Ltd, the parent company to KDL Medical Limited.

9. CONTROLLING PARTY

The company is under the control of its parent company, Shanghai Kindly Enterprises Development Group Co. Ltd.

10. GOING CONCERN

The company is reliant on the continued support of its parent company Shanghai Kindly Enterprises Development Group Co. Ltd.